Boston Family Office LLC Bristol Myers Squibb CO Transaction History

Boston Family Office LLC

  • $1.48 Billion
  • Q3 2024

A detailed history of Boston Family Office LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Family Office LLC holds 24,179 shares of BMY stock, worth $1.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
24,179
Previous 24,179 -0.0%
Holding current value
$1.4 Million
Previous $1 Million 24.6%
% of portfolio
0.08%
Previous 0.07%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$47.98 - $54.4 $112,944 - $128,057
-2,354 Reduced 8.87%
24,179 $1.31 Million
Q4 2023

Feb 12, 2024
SELL
$48.48 - $57.85 $139,040 - $165,913
-2,868 Reduced 9.75%
26,533 $1.36 Million
Q3 2023

Nov 13, 2023
BUY
$57.89 - $64.73 $44,227 - $49,453
764 Added 2.67%
29,401 $1.71 Million
Q1 2023

May 10, 2023
BUY
$65.71 - $74.53 $115,386 - $130,874
1,756 Added 6.53%
28,637 $1.98 Million
Q4 2022

Feb 07, 2023
SELL
$68.48 - $81.09 $38,348 - $45,410
-560 Reduced 2.04%
26,881 $1.93 Million
Q3 2022

Nov 08, 2022
SELL
$0.13 - $76.84 $27 - $16,213
-211 Reduced 0.76%
27,441 $1.95 Million
Q2 2022

Aug 11, 2022
SELL
$72.62 - $79.98 $19,970 - $21,994
-275 Reduced 0.98%
27,652 $2.13 Million
Q4 2021

Feb 14, 2022
BUY
$53.63 - $62.52 $14,748 - $17,193
275 Added 0.99%
27,927 $1.74 Million
Q2 2021

Aug 12, 2021
SELL
$61.91 - $67.42 $12,382 - $13,484
-200 Reduced 0.72%
27,652 $1.85 Million
Q1 2021

May 07, 2021
SELL
$59.34 - $66.74 $726,262 - $816,830
-12,239 Reduced 30.53%
27,852 $2.53 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $78,988 - $89,508
-1,368 Reduced 3.3%
40,091 $2.49 Million
Q3 2020

Nov 10, 2020
SELL
$57.43 - $63.64 $37,042 - $41,047
-645 Reduced 1.53%
41,459 $2.5 Million
Q2 2020

Aug 06, 2020
SELL
$54.82 - $64.09 $38,374 - $44,863
-700 Reduced 1.64%
42,104 $2.48 Million
Q1 2020

May 11, 2020
SELL
$46.4 - $67.43 $221,560 - $321,978
-4,775 Reduced 10.04%
42,804 $2.39 Million
Q4 2019

Feb 05, 2020
BUY
$49.21 - $64.19 $367,401 - $479,242
7,466 Added 18.61%
47,579 $3.05 Million
Q3 2019

Nov 12, 2019
SELL
$42.77 - $50.71 $42,770 - $50,710
-1,000 Reduced 2.43%
40,113 $2.03 Million
Q1 2019

May 09, 2019
SELL
$45.12 - $53.8 $12,588 - $15,010
-279 Reduced 0.67%
41,113 $1.96 Million
Q4 2018

Feb 12, 2019
SELL
$48.76 - $63.23 $34,132 - $44,261
-700 Reduced 1.66%
41,392 $2.15 Million
Q2 2018

Jul 26, 2018
SELL
$50.53 - $62.98 $13,137 - $16,374
-260 Reduced 0.61%
42,092 $2.33 Million
Q4 2017

Feb 06, 2018
BUY
$59.94 - $65.35 $89,790 - $97,894
1,498 Added 3.67%
42,352 $2.6 Million
Q3 2017

Nov 13, 2017
BUY
$55.23 - $63.74 $2.26 Million - $2.6 Million
40,854
40,854 $2.6 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email